Gold at 4 Month Low amid Continuous Progress in Vaccine

feature image
On Monday, spot gold dropped 1.8% to a 4-month low of $1,838, as sentiment was dampened by Covid-19 vaccine development. Pharmaceutical giant AstraZeneca said its Covid-19 vaccine AZD1222 achieved an average efficacy of 70% and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine. This follow promising results from Pfizer's and Moderna's vaccines.

From a technical point of view, pressure is mounting on spot gold as shown on the daily chart. It has now broken below a bearish descending triangle pattern, and has probably confirmed the bearish evening star formed in early November. The level at $1,900 might be considered as the nearest resistance, while the 1st and 2nd support are expected to be located at $1,780 and $1,735 respectively.


Source: GAIN Capital, TradingView


Related tags: commodities gold

Open an account in minutes

Experience award-winning platforms with fast and secure execution.

Sign up for our interactive livestreams

Our interactive livestreams, led by our industry experts, come highly recommended and can help provide your trading with the edge it needs.
Economic Calendar